WILLIAM METZ: Open Payments
NPI 1205366077 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 20 payments from 9 companies in 2025. Trend: 2023 $280 · 2024 $624 · 2025 $513
Food & beverage: $497Education: $12Travel & lodging: $5
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $168 |
| Ardelyx, Inc. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $37 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Mannkind Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 8 | $12 |
Products named: SYMPLICITY G3, XPHOZAH 30 MG, Kerendia, Ozempic, Fabhalta, Vanrafia, TARPEYO, AFREZZA.
Industry payments across OH — which companies pay providers there.
